VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OCUL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OCULOcular Therapeutix, Inc.
$9.90$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOCULQuarterly Financials

Ocular Therapeutix, Inc. (OCUL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ocular Therapeutix, Inc. (OCUL) quarterly income statement — complete revenue, gross profit & net income history

OCUL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue10.79M13.25M14.54M13.46M10.7M17.08M15.43M16.44M14.77M14.8M15.08M15.19M13.37M14.07M11.96M12.27M13.19M12.31M12.15M11.72M
Revenue Growth %0.81%-22.43%-5.71%-18.14%-27.59%15.41%2.28%8.26%10.47%5.16%26.04%23.81%1.42%14.36%-1.55%4.68%79.61%67.48%106.82%646.85%
Cost of Goods Sold1.33M1.59M1.77M1.94M1.26M1.23M1.56M1.51M1.33M1.39M1.38M1.3M1.21M1.01M1.07M1.16M1.3M1.11M1.31M1.1M
COGS % of Revenue12.32%12.03%12.2%14.44%11.8%7.2%10.12%9.18%8.98%9.36%9.13%8.59%9.08%7.19%8.97%9.42%9.86%9%10.78%9.35%
Gross Profit9.46M11.66M12.77M11.52M9.44M15.85M13.86M14.93M13.45M13.41M13.7M13.88M12.16M13.06M10.89M11.11M11.89M11.2M10.84M10.62M
Gross Margin %87.68%87.97%87.8%85.56%88.2%92.8%89.88%90.82%91.02%90.64%90.87%91.41%90.92%92.81%91.03%90.58%90.14%91%89.22%90.65%
Gross Profit Growth %0.21%-26.47%-7.89%-22.88%-29.83%18.17%1.17%7.56%10.59%2.69%25.82%24.94%2.3%16.63%0.45%4.6%84.29%67.94%99.83%640.21%
Operating Expenses102.8M81.42M81.47M79.16M73.35M66.43M59.86M58.52M45.06M33.47M32.92M34.45M34.71M32.42M32.44M31.03M29.72M29.25M30.37M30.85M
OpEx % of Revenue953.14%614.46%560.15%588.13%685.67%388.88%388.08%355.95%305.03%226.1%218.27%226.87%259.53%230.37%271.09%252.95%225.37%237.64%249.91%263.3%
Selling, General & Admin36.58M30.62M29.11M28.07M30.5M25.44M22.81M29.66M24.33M17.27M17.9M19.36M19.96M18.88M18.72M17.93M16.62M16.67M17.65M16.99M
SG&A % of Revenue339.2%231.06%200.15%208.6%285.06%148.92%147.86%180.43%164.68%116.68%118.69%127.47%149.26%134.15%156.43%146.15%126.03%135.45%145.26%145.02%
Research & Development66.21M50.8M52.36M51.08M42.86M40.99M37.05M28.86M20.73M16.2M15.02M15.09M14.75M13.54M13.72M13.1M13.1M12.58M12.72M13.86M
R&D % of Revenue613.94%383.4%360%379.53%400.61%239.95%240.22%175.52%140.35%109.42%99.59%99.39%110.27%96.22%114.66%106.8%99.34%102.19%104.66%118.27%
Other Operating Expenses00000000000000000000
Operating Income-93.34M-69.76M-68.7M-67.64M-63.92M-50.58M-46M-43.59M-31.62M-20.05M-19.21M-20.57M-22.55M-19.36M-21.54M-19.92M-17.83M-18.05M-19.53M-20.23M
Operating Margin %-865.46%-526.49%-472.35%-502.57%-597.47%-296.08%-298.2%-265.13%-214%-135.46%-127.41%-135.45%-168.6%-137.56%-180.06%-162.37%-135.23%-146.64%-160.69%-172.65%
Operating Income Growth %-46.03%-37.93%-49.35%-55.18%-102.16%-152.25%-139.4%-111.91%-40.21%-3.56%10.82%-3.28%-26.45%-7.27%-10.32%1.56%11.84%-25.84%-39.43%-13.12%
EBITDA-92.06M-68.51M-67.63M-66.61M-62.94M-49.63M-45.04M-42.63M-30.7M-19.09M-18.32M-19.92M-22.07M-18.87M-21.04M-19.36M-17.28M-17.48M-18.93M-19.62M
EBITDA Margin %-853.57%-517.08%-464.98%-494.95%-588.3%-290.51%-291.99%-259.32%-207.78%-128.99%-121.5%-131.16%-164.99%-134.07%-175.8%-157.87%-131.01%-142.01%-155.81%-167.43%
EBITDA Growth %-46.27%-38.06%-50.15%-56.25%-105.02%-159.93%-145.79%-114.05%-39.11%-1.18%12.89%-2.86%-27.73%-7.96%-11.09%1.3%11.78%-27.81%-41.93%-14.22%
D&A (Non-Cash Add-back)1.28M1.25M1.07M1.03M981K951K959K956K920K958K890K652K483K491K509K552K557K570K594K611K
EBIT-93.34M-61.82M-66.42M-64.8M-61.07M-45.28M-33.27M-40.58M-60.8M-25.07M2.91M-18.69M-28.55M-13.7M-22.39M-17.07M-10.86M-2.17M4.32M-6.83M
Net Interest Income3.27M4.51M727K439K842K1.56M2.43M2.84M-129K-2.69M-2.21M-1.24M-1.21M-1.42M-1.51M-1.62M-1.67M-1.67M-1.65M-1.65M
Interest Income6.05M7.34M3.73M3.46M3.83M4.67M5.65M6.04M3.92M1.46M1.21M748K563K423K285K73K18K6K7K8K
Interest Expense2.78M2.83M3M3.02M2.98M3.11M3.22M3.2M4.05M4.15M3.43M1.99M1.77M1.85M1.8M1.7M1.68M1.68M1.66M1.66M
Other Income/Expense4.73M5.11M-720K-173K-136K2.19M9.51M-187K-33.23M-9.17M18.7M-112K-7.77M3.82M-2.64M1.15M5.29M14.2M22.19M11.75M
Pretax Income-88.61M-64.65M-69.42M-67.81M-64.05M-48.39M-36.49M-43.78M-64.85M-29.22M-516K-20.68M-30.32M-15.54M-24.19M-18.77M-12.54M-3.85M2.66M-8.48M
Pretax Margin %-821.62%-487.95%-477.3%-503.86%-598.74%-283.27%-236.58%-266.27%-438.93%-197.42%-3.42%-136.19%-226.69%-110.42%-202.16%-152.99%-95.11%-31.28%21.86%-72.38%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-88.61M-64.65M-69.42M-67.81M-64.05M-48.39M-36.49M-43.78M-64.85M-29.22M-516K-20.68M-30.32M-15.54M-24.19M-18.77M-12.54M-3.85M2.66M-8.48M
Net Margin %-821.62%-487.95%-477.3%-503.86%-598.74%-283.27%-236.58%-266.27%-438.93%-197.42%-3.42%-136.19%-226.69%-110.42%-202.16%-152.99%-95.11%-31.28%21.86%-72.38%
Net Income Growth %-38.34%-33.62%-90.22%-54.91%1.23%-65.6%-6972.29%-111.67%-113.89%-88.01%97.87%-10.21%-141.73%-303.69%-1010.35%-121.27%-501.86%95.5%122.25%76.81%
Net Income (Continuing)-88.61M-64.65M-69.42M-67.81M-64.05M-48.39M-36.49M-43.78M-64.85M-29.22M-516K-20.68M-30.32M-15.54M-24.19M-18.77M-12.54M-3.85M2.66M-8.48M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.40-0.29-0.38-0.39-0.38-0.29-0.22-0.26-0.49-0.20-0.25-0.26-0.39-0.24-0.31-0.25-0.22-0.23-0.23-0.25
EPS Growth %-5.26%0%-72.73%-50%22.45%-45%12%0%-25.64%16.67%19.35%-4%-77.27%-4.35%-34.78%0%8.33%80.99%-35.29%60.94%
EPS (Basic)-0.40-0.29-0.38-0.39-0.38-0.29-0.22-0.26-0.49-0.21-0.27-0.26-0.39-0.25-0.31-0.27-0.24-0.24-0.26-0.27
Diluted Shares Outstanding224.1M222.92M183.92M172.59M169.4M168.02M166.99M165.82M132.02M108.81M85.14M78.05M77.39M82.78M76.98M82.53M82.51M82.39M85.45M82.09M
Basic Shares Outstanding224.1M222.92M183.92M172.59M169.4M168.02M166.99M165.82M132.02M105.92M79.37M78.05M77.39M77.01M76.98M76.76M76.75M76.62M76.55M76.32M
Dividend Payout Ratio--------------------